SUMMARY TERM SHEET. Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL )

Similar documents
These Rules of Membership apply in respect of all Products purchased by a Member from Sigma (and any Program Partner) on or after 1 February 2017.

PRICE DEMERS & CO. Barristers, Solicitors & Notaries Public

RULES OF CONDUCT OF INSIDERS RESPECTING

PROSPECTUS. Offer of up to 300,000 Convertible Resettable Preference Shares to raise up to $30,000,000. Whitefield Limited ABN

CITY OF VALLEJO HIDDENBROOKE IMPROVEMENT DISTRICT NO IMPROVEMENT LEVY ADMINISTRATION REPORT FISCAL YEAR

Development Bank of Southern Africa Amendment Bill [B ]

MINUTES OF THE ANNUAL SOLVAY S.A. SHAREHOLDERS MEETING On Tuesday, May 10, 2016 at 10:30 a.m.

Development Bank of Southern Africa Amendment Bill [B ]

ESM Pricing Policy. Element of Pricing and Calculation of Interest Rate. 1. Base Rate

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q

1Q Fornebu, April 29, 2015 Luis Araujo and Svein Stoknes

ObsEva Reports Third Quarter 2017 Financial Results and Provides Business Update

Summary of Results for the First Half of FY2015/3

Annual General Meeting of Shareholders of Philip Morris ČR a.s. Kutná Hora April 25, András Tövisi Chairman of the Board of Directors

CENTRALE. Monetary. compared. domestic. million.

Organisational reporting of completion fees apply

Aerpio Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update

THIRD QUARTER REPORT 2011 (UNAUDITED)

Operational Efficiency:

FY2007 Consolidated Financial Overview

MEMORANDUM ASSOCIATION

All CRPS will have a maturity date of 18 months from the date of issuance of the first tranche of CRPS ( Maturity Date ).

General Terms and Conditions

MANAGEMENT. MGMT 0021 THE MANAGEMENT PROCESS 3 cr. MGMT 0022 FINANCIAL ACCOUNTING 3 cr. MGMT 0023 MANAGERIAL ACCOUNTING 3 cr.

Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company)

GENERAL TERMS AND CONDITIONS WCO PUBLICATIONS

DRAFT FOR PUBLIC COMMENT Guidance Note for ESS9 Financial Intermediaries

Q Investor Kit JANUARY-MARCH 2014

BVI Limited Partnership Hedge Funds: Calling Japan

Family Application: Nanny / Mother s Helper

ObsEva Reports First Quarter 2018 Financial Results and Provides Business Update

Interim report Second quarter 2017 and subsequent events (Unaudited)

Growth of s 1 lac invested on inception date. SIP Performance: Scheme Name 1 Yr 2 Yr 3 Yr 4 Yr 5 Yr. CNX Midcap

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q

For personal use only

Dainippon Pharmaceutical and Sumitomo Pharmaceuticals Finalize Merger Agreement

General Terms and Conditions

Telekom Austria Group Results for the 1st Quarter May 27, 2003

Q Investor Kit January December 2014

Terms & Conditions of Trade

NewLink Genetics Corporation Provides Operational Update and Reports Second Quarter 2015 Financial Results

1Q2017 法人說明會 Jun. 9, 2017

DIEBOLD NIXDORF AG AT GERMANY EQUITY FORUM

Q Investor Kit JANUARY-JUNE 2013

Oncolytics Biotech Inc. Announces Third Quarter 2010 Results

ObsEva Reports Third Quarter 2018 Financial Results and Provides Business Update

Investor Relations 1Q 2017

Q Investor Kit JANUARY-MARCH 2013

Q2 INVESTOR KIT JANUARY-JUNE 2011

Sumitomo Pharmaceuticals reaches a basic agreement to merge with Dainippon Pharmaceutical

Interim Report 1 January September 2017

NHS: 2005 PCA(D)11 abcdefghijklm

ThromboGenics Business Update H1 2018

Argos Therapeutics Reports Fourth Quarter and Year-End 2013 Financial Results

Q Investor Kit January December 2015

Q Investor Kit JANUARY-JUNE 2014

CPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018

Name and address of the Borrower

INVESTOR PRESENTATION

FORM8-K HILLENBRAND,INC.

Company overview. Highlights for the 1 st quarter 2018 (January-March)

Legal framework for the development of commodity based financing. Krassimir Kiriakov International WHR Expert

Investor Presentation

Acquisition of Novartis Influenza Vaccines Business. 27 th October 2014

2017 Annual General Meeting

AFFIN HOLDINGS BERHAD (Company No.: W) (Incorporated in Malaysia under the Companies Act, 2016) NOTICE TO SHAREHOLDERS IN RELATION TO THE

BANK HANDLOWY W WARSZAWIE S.A. 1Q 2009 consolidated financial results -1-

1Q 2015 Results A Positive Start to 2015

THE GYMNASIUMS AND FITNESS CENTRES (REGULATION) BILL, 2016

5). Loving Nannies will fax or mail you the background check and your caregiver can officially start!

YEAR END REPORT. September 2013 August Diamyd Medical AB (publ), Fiscal year 2013/2014

Family Application: Nanny / Mother s Helper

APPENDIX 4C SEPTEMBER 2018 QUARTER

AMERICAN BOARD OF ADOLESCENT PSYCHIATRY

PROACTIVE INVESTOR PRESENTATION

No.Ayur-Ja (7)-1/97-III Dated, Shimla-2, the NOTIFICATION. In supersession of this Department s Office Order of even number

DELICA D:5 ACTIVE GEAR 0

WntResearch. 100% one-week return? 16 October 2017 PRICE EXPECTATIONS INVESTMENT CASE PRICE TRIGGERS PRICE 12 MONTHS COMPANY PROFILE

RULES. on Selection and Sale of Tobacco and Trade Terms with Suppliers CHAPTER I

HILLENBRAND INDUSTRIES INC

Altria Group Inc. Ticker: MO

Tandem Diabetes Care, Inc. (TNDM) - Medical Equipment - Deals and Alliances Profile

ŚCIŚLE POUFNE. The Company's presentation

Industry experience in consortium i.e. from BEE party or non-bee partners

Explanatory Memorandum to accompany the National Health Service (Dental Charges) (Wales) (Amendment) Regulations 2018

Hong Leong Bank Berhad (97141 X) A Member of the Hong Leong Group. A Member of the Hong Leong Group ANNUAL REPORT 2008

Second Regular Session Seventieth General Assembly STATE OF COLORADO INTRODUCED

Investor Presentation

QuickBooks Online Student Guide. Education Exercises Answer Key

Invion Limited (ASX:IVX) Clinical-stage life sciences company targeting chronic inflammation

SPHERIX ANNOUNCES FIRST QUARTER 2010 FINANCIAL RESULTS

HONG LEONG DEPOSIT & WIN CONTEST

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183)

28 April 2017 ASX Code: COY. March 2017 Quarterly Activity Report

Non Performing Assets (NPAs): A Comparative Analysis of SBI and ICICI Bank

Evofem Biosciences Reports Second Quarter 2018 Financial Results and Provides Corporate Update

FY2009 First Quarter Financial Results. SUZUKI MOTOR CORPORATION August 3, 2009

Enel Américas 1Q 2018 results

1Q 2009 Results Presentation. 12 May 2009

Pink Bollworm Control Act

Transcription:

SUMMARY TERM SHEET Sl. Particulars Details 1. Issuer L&T Finance Holdings Limited (the Company / the Issuer / L&TFHL ) 2. Date of resolution May 28, 2014 passed by the Board of Directors authorizing the Issue 3. Date of special July 24, 2014 (Annual General Meeting) resolution passed by the shareholders authorizing the Issue 4. Instrument Rated Listed Cumulative Compulsorily Redeemable Non- Convertible Preference Shares ( CRPS ) 5. Seniority Claims of the CRPS Holders shall rank senior to claims of any holder of equity shares of the Company and shall rank pari passu with all other preference shares issued by the Company. Claims of the CRPS Holder shall be subordinated to the both secured and unsecured creditors of the Company 6. Mode of Issue Private Placement 7. Listing BSE Limited CRPS shall be listed within 20 days from the Deemed Date of Allotment 8. Rating CARE AA+(RPS) by CARE. Instruments with this rating are considered to have high degree of safety regarding timely servicing of financial obligations. Such instruments carry very low credit risk. 9. Issue Size 4,00,00,000 CRPS aggregating to Rs. 400,00,00,000 10. Option to retain Up to 2,00,00,000 CRPS aggregating up to Rs. 200,00,00,000 oversubscription 11. Objects of the Issue The funds raised through this Issue shall be utilized to maintain adequate working capital as may be required for funding the operations of the Company and that of its subsidiaries. 12. Utilization of Issue proceeds 13. Interest on Application Money The Company shall utilize the proceeds of the Issue solely for meeting the Objects of the Issue as stated in the Information Memorandum The Company shall pay to the successful applicants, interest at the rate of 8.15% p.a. on the amount allotted, from and including the date of receipt of application money in the Designated Account till one day prior to Deemed Date of Allotment, subject to applicable tax laws.

14. Interest on Refund Amount (excluding the valid rejections) The Company shall pay to the successful applicants, interest at the rate of 8.15% p.a. on the refund amount, from and including the date of receipt of the money in the Designated Account till one day prior to Deemed Date of Allotment, subject to applicable tax laws. However, the Company shall not be liable to pay any interest on monies liable to be refunded in case of: a) Invalid Applications/ or Applications liable to be rejected; b) Applications which are withdrawn by the Applicant(s); c) Monies paid in excess of the amount of CRPS applied for in the Application Form. 15. Face Value Rs. 100 per CRPS 16. Premium/ Discount Nil on Issue 17. Issue Price Rs. 100 per CRPS 18. Tenor 5 years (60 months) from the Deemed Date of Allotment 19. Redemption Date* May 08, 2020 * Redemption Date may change based on the actual Deemed Date of Allotment. 20. Dividend Rate 8.15% p.a. 21. Dividend Payment Annual Frequency 22. Redemption Nil Premium/ Discount 23. Redemption Price Rs. 100 per CRPS 24. Redemption Amount Rs. 100 per CRPS plus any Dividend accrued but not paid from any previous Dividend Payment Date 25. Put / Call Option None 26. Put Option Date Not Applicable 27. Put Option Price Not Applicable 28. Put Notification Not Applicable Time 29. Call Option Date Not Applicable 30. Call Option Price Not Applicable 31. Call Notification Not Applicable Time 32. Minimum Application and in multiples thereafter Rs. 1.00 crore (1,00,000 CRPS) and in multiples of Rs. 25 lac (25,000 CRPS) thereafter

33. Dividend Payment Dates and Redemption Date Dividend Payment Dates and Redemption Date Revised Dividend Payment Date and Redemption Date Dividend for the period From and including Upto and including For the financial year No. of days Amount payable per CRPS (Rs.), 06-May-2015^ - - - - - -100.0000 Sat, 26-Mar-2016 Mon, 28-Mar-2016 06-May-2015 31-Mar-2016 2015-16 329 7.3706 Sun, 26-Mar-2017 Mon, 27-Mar-2017 01-Apr-2016 31-Mar-2017 2016-17 365 8.1500 Mon, 26-Mar-2018-01-Apr-2017 31-Mar-2018 2017-18 365 8.1500 Tue, 26-Mar-2019-01-Apr-2018 31-Mar-2019 2018-19 365 8.1500 Thu, 26-Mar-2020-01-Apr-2019 31-Mar-2020 2019-20 366 8.1500 Wed, 06-May- 2020* Notes & Assumptions: - 01-Apr-2020 06-May-2020 2020-21 37 100.7815 ^ Adjustment of application money paid by the Investors on account of allotment of CRPS. * Inclusive of redemption amount of Rs. 100 per CRPS. a. Dividend amount has been calculated @ 8.15% p.a. rounded off to four decimals per CRPS. The amount of Dividend payable may vary subject to the Accelerated Redemption Clause. b. In pursuance of clause on Business Day Convention, all days (other than Saturdays and Sundays) on which the banks are open for business in Mumbai, have been considered as Business Days. c. The first Dividend Payment Date is falling on 26-Mar-2016, which is a Saturday and therefore not a Business Day. Likewise the second Dividend Payment Date is falling on 26- Mar-2017, which is a Sunday and therefore not a Business Day.As per Business Day Convention, if any Dividend Payment Date falls on a day that is not a Business Day, payment shall be made on the immediately succeeding Business Day without any obligation for paying dividend for the intervening period. Therefore the first Dividend Payment shall be made on 28-Mar-2016 (immediately succeeding Business Day) and second Dividend Payment shall be made on 27-Mar-2017 (immediately succeeding Business Day), without any obligation for paying dividend for the intervening period. d. For the purpose of the above illustration, it has been assumed that only Saturdays and Sundays are non-business Days. The notified/ gazette/ other bank holidays cannot be ascertained as of now and therefore their impact has not been captured in the above illustration. e. If the Deemed Date of Allotment is preponed/ postponed, the Redemption Date shall also stand modified and the amount of Dividend payable on the first and the last Dividend Payment Date shall also undergo change. 34. Change in Tax In the event of any change in applicable tax laws on account of which

Laws Rights of CRPS Holders Mode of redemption Issuance Mode Trading Mode the Dividend received by the CRPS Holders becomes subject to any tax to the account of the CRPS Holders, the Company shall declare and pay such additional amounts as Dividend such that the total amount received by the CRPS Holders as Dividend ( Aggregate Dividend Rate ) in relation to the CRPS less the tax payable on account of the change in applicable law is equivalent to the Dividend Rate as set out above. However, in the event of such change in applicable tax laws, the Company reserves the right to exercise the Accelerated Redemption Clause wherein the redemption of CRPS may be preponed as described below. In pursuance of sub-section (2) of section 47 of the Companies Act, 2013, every member of a Company and holding any CRPS shall, in respect of such capital, have a right to vote only on resolutions placed before the Company which directly affect the rights attached to his CRPS and, any resolution for the winding up of the Company or for the repayment or reduction of its equity or preference share capital and his voting right on a poll shall be in proportion to his share in the paid-up preference share capital of the Company. Provided that the proportion of the voting rights of equity shareholders to the voting rights of the holders of CRPS shall be in the same proportion as the paid-up capital in respect of the equity shares bears to the paid-up capital in respect of the CRPS. However in case where the dividend in respect of CRPS has not been paid for a period of two years or more, such CRPS Holders shall have a right to vote on all the resolutions placed before the Company. The CRPS shall be redeemed out of profits of the Company which would otherwise be available for Dividend or out of the proceeds of a fresh issue of shares made for the purposes of such redemption. Demat only Demat only Background of the company: L&TFHL is promoted by L&T and was incorporated as L&T Capital Holdings Limited on May 01, 2008, under the Companies Act, 1956, to carry on the business of investment/finance and received the certificate of commencement of business on May 15, 2008. Subsequently, the company changed the name to L&T Finance Holdings Limited from September 01, 2010, and received fresh certificate of incorporation from the Registrar of Companies on September 06, 2010. Prior to March 31, 2009, L&TFH had minimal operations with passive investments. It acquired 100% stake in L&T Finance Limited (LTF) and L&T Infrastructure Finance Limited (L&T Infra) on March 31, 2009. The company came up with an Initial Public Offer (IPO) during FY12 (refers to the period April to March), consequent to which, the stake of L&T diluted to 82.64%. However, L&T continues to hold controlling stake in the company and the management of L&TFHL is mainly drawn from the senior management of L&T. Financial Background: L&TFHL reported a consolidated Profit After Tax (PAT) of Rs.597 crore on a total income of Rs.5,237 crore in FY14 as compared with a PAT of Rs.730 crore on a total income of Rs.3,995 crore in FY13. In Q1FY15, the company reported PAT of Rs.286 crore on total income of Rs.1,469 crore. Rating Rationale by CARE

The rating factors in the strategic importance of L&T Finance Holdings Ltd (L&TFHL) to the L&T group as the flagship holding company of its financial services business, brand value of L&T, experienced management, L&TFH s strong consolidated financial position, and strong resource-raising ability. The rating further factors in L&TFH s well-diversified business profile in the financial sector through its direct and indirect subsidiaries that have good presence and track record in segments like retail finance, corporate finance, infrastructure finance and asset management services as well as the profitability track record of its subsidiaries. Continued support from L&T, profitability and the asset quality of loan portfolio of its subsidiaries are the key rating sensitivities. Source: CARE Credit Rating